XFOR stock forecast
Our latest prediction for X4 Pharmaceuticals Inc's stock price was made on the Feb. 13, 2024 when the stock price was at 0.92$.
In the short term (2weeks), XFOR's stock price should underperform the market by -2.45%. During that period the price should oscillate between -23.83% and +18.34%.
In the medium term (3months), XFOR's stock price should underperform the market by -5.32%. During that period the price should oscillate between -62.66% and +43.19%.
Get email alertsCreate a solid portfolio with XFOR
About X4 Pharmaceuticals Inc
x4 pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and reverse immune suppression, which is fundamental to treating cancer and certain rare, genetic primary immunodeficiency diseases. our oral, small molecule drug candidates inhibit the binding of chemokine cxcl12 to c-x-c receptor type 4 (cxcr4), a receptor-ligand pair that plays an essential role in normal immune surveillance. we are committed to advancing the fields of cancer immunotherapy and genetic immune disorders through innovation and investment in our proprietary clinical and preclinical pipeline. x4’s most advanced product candidate, x4p-001-rd, is in a phase 2/3 study in patients with whim syndrome, a rare genetic, primary immunodeficiency disease. x4p-001-io is currently under investigation in multiple phase 1/2 studies in refractory clear cell renal cell carcinoma (ccrcc) and melanoma. our third program, x4p-002, is in preclinical development and designed specifically for the t
At the moment the company generates 12M USD in revenues.
On its last earning announcement, the company reported a loss of -0.95$ per share.
The book value per share is 8.01$
Three months stock forecastFeb. 13, 2024
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
12M | - | -107M | - | -52M | -0.95 | - | - | 164M | 8.01 | - | - | - |